Vilin Bio Med Reports H1 FY27 Results with Strong Revenue Growth
Vilin Bio Med Ltd · Outcome · 14 Nov 2026, 10:49 pm
Vilin Bio Med Reports H1 FY27 Results with Strong Revenue Growth Vilin Bio Med reported standalone revenue from operations of ₹3,260.00 lakhs for the half-year ended 30th Sep'26, jumping 237.33% YoY from ₹966.40 lakhs. Standalone net profit surged to ₹128.16 lakhs versus ₹15.17 lakhs in the previous corresponding period, driving EPS up to ₹0.84 from ₹0.11 YoY. On a consolidated basis, net profit stood at ₹127.86 lakhs. The company fully utilized its ₹338.00 lakhs preferential issue proceeds raised on 4th Mar'26 primarily for working capital (₹327.00 lakhs) with zero deviations.
Original exchange filing (PDF)
More announcements from Vilin Bio Med Ltd
- VILIN BIO MED LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Vilin Bio Med Limited has informed the Exchange that, being listed on the NSE Emerge Platform, the Company is exempt from the applicable Corporate Governance requirements. However, the Company is voluntarily submitting the Integrated Corporate Governance Report for the period ended September 30, 2026. · 27 Oct 2026
- Vilin Bio Med Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on October 15, 2026. Further, the company has informed the Exchange regarding voting results. · 16 Oct 2026
- Vilin Bio Med Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on October 15, 2026 · 15 Oct 2026
- Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on September 15, 2026. · 16 Sept 2026
- Vilin Bio Med Limited has informed the Exchange regarding 'General Updates'. · 15 Sept 2026
- Vilin Bio Med Limited has informed the Exchange regarding 'General Updates'. · 15 Sept 2026
